Novel Levodopa Delivery System Promises Continuous Dosing
Called DopaFuse, the experimental device is designed to deliver the levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
Source: medscape.com
Stay updated with breaking news from L Dopa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Called DopaFuse, the experimental device is designed to deliver the levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
Continuous infusion strategies have long been sought as a method to preserve levodopa efficacy.
Patients often hide their hallucinations, which are associated with poor long-term outcomes and a reduced quality of life.
Acorda was awarded $15 million plus prejudgment interest of $1.5 million from Alkermes.